Kiniksa Pharmaceuticals International Plc (KNSA)

Aug 13, 2025

Insider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Insider Sells 29,325 Shares of Stock - MarketBeat

Aug 13, 2025

Aug 13, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Shares Purchased by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Aug 13, 2025

Aug 12, 2025

Eben Tessari Sells 138,614 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat

Aug 12, 2025

Aug 11, 2025

Michael R. Megna Sells 17,000 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat

Aug 11, 2025

Aug 10, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) CFO Sells $621,259.21 in Stock - MarketBeat

Aug 10, 2025

Aug 09, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month HighShould You Buy? - MarketBeat

Aug 09, 2025

Aug 08, 2025

BIT Capital GmbH Takes $264,000 Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Aug 08, 2025

Aug 07, 2025

J.P. Morgan Maintains Buy Rating on Kiniksa Pharmaceuticals with $55 Price Target - AInvest

Aug 07, 2025

Aug 05, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Is Up 21.46% in One Week: What You Should Know - Yahoo Finance

Aug 05, 2025

Aug 05, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded at Wall Street Zen - Defense World

Aug 05, 2025

Aug 05, 2025

Wedbush Issues Positive Outlook for KNSA Earnings - MarketBeat

Aug 05, 2025

Aug 04, 2025

Kiniksa Pharmaceuticals surges 11.01% on Arcalyst's market penetration - AInvest

Aug 04, 2025

Aug 04, 2025

Victory Capital Management Inc. Makes New Investment in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Aug 04, 2025

Aug 02, 2025

Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect? - MSN

Aug 02, 2025

Aug 02, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High After Earnings Beat - MarketBeat

Aug 02, 2025

Aug 02, 2025

Equities Analysts Set Expectations for KNSA Q3 Earnings - Defense World

Aug 02, 2025

Aug 01, 2025

Why Kiniksa Pharmaceuticals International, plc (KNSA) Might be Well Poised for a Surge - Yahoo Finance

Aug 01, 2025

Aug 01, 2025

Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going - Yahoo Finance

Aug 01, 2025

Jul 31, 2025

Victory Capital Management Inc. Takes $1.18 Million Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 31, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals Achieves 52% YoY Growth in Q2 2025, Raises Revenue Guidance - AInvest

Jul 30, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q2 Earnings and Revenue Estimates - MSN

Jul 30, 2025

Jul 30, 2025

Kiniksa raises ARCALYST 2025 revenue guidance to $625M-$640M as patient penetration rises - MSN

Jul 30, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 30, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals International Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Jul 30, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals International PLC (KNSA) Q2 2025 Earnings Call Highlights: Record ... - Yahoo Finance

Jul 30, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals International PLC (KNSA) Q2 2025 Earnings Call Highlights: Record ... By GuruFocus - Investing.com Canada

Jul 30, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 1-Year High After Strong Earnings - Defense World

Jul 30, 2025

Jul 30, 2025

Kiniksa Pharmaceuticals Reports Strong Q2 2025 Growth - TipRanks

Jul 30, 2025

Jul 29, 2025

Kiniksa: Jefferies maintains Buy, raises PT to $54 from $45. - AInvest

Jul 29, 2025

Jul 29, 2025

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution - GlobeNewswire

Jul 29, 2025

Jul 29, 2025

Kiniksa Pharmaceuticals Q2 2025 Earnings Call Transcript: Key Highlights and Financial Results - AInvest

Jul 29, 2025

Jul 29, 2025

Kiniksa Pharmaceuticals stock hits 52-week high at 30.8 USD By Investing.com - Investing.com Nigeria

Jul 29, 2025

Jul 29, 2025

Kiniksa Pharmaceuticals International Q2 2025 Earnings Call Transcript - MarketBeat

Jul 29, 2025

Jul 29, 2025

Kiniksa Pharmaceuticals Reports Q2 2025 Financial Results with 52% Growth in ARCALYST Revenue and Updates on Clinical Trials - Quiver Quantitative

Jul 29, 2025

Jul 29, 2025

Kiniksa Crushes Earnings: ARCALYST Sales Jump 52%, Company Raises 2025 Revenue Target to $640M - Stock Titan

Jul 29, 2025

Jul 28, 2025

Kiniksa Pharmaceuticals Q2 2025 Earnings Preview: $0.22 EPS, $145.21M Revenue Expected - AInvest

Jul 28, 2025

Jul 28, 2025

Cwm LLC Purchases 19,828 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Jul 28, 2025

Jul 27, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of “Buy” by Analysts - Defense World

Jul 27, 2025

Jul 27, 2025

Analysts Set Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) PT at $39.67 - MarketBeat

Jul 27, 2025

Jul 27, 2025

Kiniksa Pharmaceuticals Announces Q2 2025 Financial Results Conference Call. - AInvest

Jul 27, 2025

Jul 25, 2025

Kiniksa Pharmaceuticals International PLC expected to post earnings of 18 cents a shareEarnings Preview - TradingView

Jul 25, 2025

Jul 25, 2025

Cwm LLC Has $491,000 Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 25, 2025

Jul 24, 2025

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire

Jul 24, 2025

Jul 24, 2025

Kiniksa Pharmaceuticals Q2 2025 Earnings: Key Financial Results Coming July 29How to Join - Stock Titan

Jul 24, 2025